How Yuhan's Open Innovation is Revolutionizing Drug Development in Asia
AI 요약 정보
- Yuhan's Choi urges biotech and drugmakers to pool strengths
- Yuhan licensed in lazertinib in 2015; out to Janssen in 2018
- Yuhan builds an own preclinical pipeline and TPD platform